Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient

Chest

Volumn 151, Issue 3, 2017, Pages 697-706

  deBacker, Julian ^a,c   Hart, Nicholas ^b   Fan, Eddy ^c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

airway management; critical care; intensive care units; mechanical ventilation; neuromuscular blocking agents

Indexed keywords

AMINOGLYCOSIDE; ATRACURIUM BESILATE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CISATRACURIUM; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN; EDROPHONIUM; FUROSEMIDE; GLYCOPYRRONIUM; INHALATION ANESTHETIC AGENT; LITHIUM; LOCAL ANESTHETIC AGENT; MIVACURIUM; NEOSTIGMINE; PANCURONIUM; PHENYTOIN; PYRIDOSTIGMINE; RANITIDINE; ROCURONIUM; SUXAMETHONIUM; THEOPHYLLINE; VANCOMYCIN; VECURONIUM; NEUROMUSCULAR BLOCKING AGENT;

ABDOMINAL PRESSURE; ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMATIC STATE; CRITICALLY ILL PATIENT; ENDOTRACHEAL INTUBATION; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LUNG VENTILATION; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; OUT OF HOSPITAL CARDIAC ARREST; PARALYSIS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; RISK FACTOR; TACHYPHYLAXIS; VENOUS THROMBOEMBOLISM; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; DISEASE MANAGEMENT; HEART ARREST; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; STATUS ASTHMATICUS;

CRITICAL CARE; CRITICAL ILLNESS; DISEASE MANAGEMENT; HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; INTENSIVE CARE UNITS; INTRACRANIAL HYPERTENSION; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; STATUS ASTHMATICUS;

EID: 85014565448     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.10.040     Document Type: Review

References (73)

1. 1 Murray, M.J., Cowen, J., DeBlock, H., et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:1 (2002), 142–156.
2. 2 Miller, R.D., Neuromuscular blocking drugs. Miller, R.D., Pardo, M.C., (eds.) Basics of Anesthesia, 2011, Elsevier, Philadelphia, PA, 143–161.
3. 3 Naguib, M., Lien, C.A., Pharmacology of muscle relaxants and their antagonists. Miller, R.D., (eds.) Miller's Anesthesia, 6th ed., 2005, Churchill Livingstone, Philadelphia, PA, 481–572.
4. 4 Warr, J., Thiboutot, Z., Rose, L., Mehta, S., Burry, L.D., Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Ann Pharmacother 45:9 (2011), 1116–1126.
5. 5 Greenberg, S.B., Vender, J., The use of neuromuscular blocking agents in the ICU: Where are we now?. Crit Care Med 41:5 (2013), 1332–1344.
6. 6 Price, D., Kenyon, N.J., Stollenwerk, N., A fresh look at paralytics in the critically ill: real promise and real concern. Ann Intensive Care 2:1 (2012), 43–52.
7. 7 Martyn, J.A., White, D.A., Gronert, G.A., Jaffe, R.S., Ward, J.M., Up-and-down regulation of skeletal muscle acetylcholine receptors: effects on neuromuscular blockers. Anesthesiology 76:5 (1992), 822–843.
8. 8 Tran, D.T., Newton, E.K., Mount, V.A., Lee, J.S., Wells, G.A., Perry, J.J., Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev(10), 2015, CD002788.
9. 9 Prielipp, R.C., Coursin, D.B., Applied pharmacology of common neuromuscular blocking agents in critical care. New Horiz 2:1 (1994), 34–47.
10. 10 Bevan, D.R., Donati, F., Kopman, A.F., Reversal of neuromuscular blockade. Anesthesiology 77:4 (1992), 785–805.
11. 11 Abrishami, A., Ho, J., Wong, J., Yin, L., Chung, F., Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev(4), 2009, CD007362.
12. 12 Mehta, S., Burry, L., Fischer, S., et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 34:2 (2006), 374–380.
13. 13 Jaber, S., Amraoui, J., Lefrant, J.Y., et al. Clinical practice and risk factors for immediate complications of endotracheal intubation in the intensive care unit: a prospective, multiple-center study. Crit Care Med 34:9 (2006), 2355–2361.
14. 14 Wilcox, S.R., Bittner, E.A., Elmer, J., et al. Neuromuscular blocking agent administration for emergent tracheal intubation is associated with decreased prevalence of procedure-related complications. Crit Care Med 40:6 (2012), 1808–1813.
15. 15 Booij, L., Appropriate use of muscle relaxants in anaesthesia, intensive and emergency care. Jurnalul Roman Anestezie Ter Intensiv 18:2 (2011), 136–144.
16. 16 Jones, R.K., Caldwell, J.E., Brull, S.J., Soto, R.G., Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 109:5 (2008), 816–824.
17. 17 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:18 (2000), 1301–1308.
18. 18 Amato, M.B., Meade, M.O., Slutsky, A.S., et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372:8 (2015), 747–755.
19. 19 Bellani, G., Laffey, J.G., Pham, T., et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA, 315(8), 2016, 788.
20. 20 Bishop, M.J., Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. Anesthesiology 60:4 (1984), 369–371.
21. 21 Yoshida, T., Torsani, V., Gomes, S., et al. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med 188:12 (2013), 1420–1427.
22. 22 Akoumianaki, E., Lyazidi, A., Rey, N., et al. Mechanical ventilation-induced reverse-triggered breaths: a frequently unrecognized form of neuromechanical coupling. Chest 143:4 (2013), 927–938.
23. 23 Pohlman, M.C., McCallister, K.E., Schweickert, W.D., et al. Excessive tidal volume from breath stacking during lung-protective ventilation for acute lung injury. Crit Care Med 36:11 (2008), 3019–3023.
24. 24 Forel, J.M., Roch, A., Marin, V., et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34:11 (2006), 2749–2757.
25. 25 Gainnier, M., Roch, A., Forel, J.M., et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 32:1 (2004), 113–119.
26. 26 Ware, L.B., Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 33:3 suppl (2005), S217–S222.
27. 27 Papazian, L., Forel, J.M., Gacouin, A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:12 (2010), 1107–1116.
28. 28 Needham, C.J., Brindley, P.G., The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Can J Anesth 59:1 (2012), 105–108.
29. 29 Slutsky, A.S., Tremblay, L.N., Multiple system organ failure: Is mechanical ventilation a contributing factor?. Am J Respir Crit Care Med 157:6 (1998), 1721–1725.
30. 30 Neto, A.S., Pereira, V.G., Esposito, D.C., Damasceno, M.C., Schultz, M.J., Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care 2:1 (2012), 33–40.
31. 31 Levy, B.D., Kitch, B., Fanta, C.H., Medical and ventilatory management of status asthmaticus. Intensive Care Med 24:2 (1998), 105–117.
32. 32 Leatherman, J., Mechanical ventilation for severe asthma. Chest 147:6 (2015), 1671–1680.
33. 33 Behbehani, N.A., Al-Mane, F., D'yachkova, Y., Paré, P., FitzGerald, J.M., Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115:6 (1999), 1627–1631.
34. 34 Adnet, F., Dhissi, G., Borron, S.W., et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 27:11 (2001), 1729–1736.
35. 35 Kesler, S.M., Sprenkle, M.D., David, W.S., Leatherman, J.W., Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis. Intensive Care Med 35:1 (2009), 157–160.
36. 36 Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma 24:suppl 1 (2007), S55–S58.
37. 37 Rangel-Castillo, L., Gopinath, S., Robertson, C.S., Management of intracranial hypertension. Neurol Clin 26:2 (2008), 521–541.
38. 38 Schramm, W.M., Papousek, A., Michalek-Sauberer, A., Czech, T., Illievich, U., The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients. Anesth Analg 86:1 (1998), 123–127.
39. 39 The Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome, Kirkpatrick, A.W., Roberts, D.J., et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 39:7 (2013), 1190–1206.
40. 40 Hsiang, J.K., Chesnut, R.M., Crisp, C.B., Klauber, M.R., Blunt, B.A., Marshall, L.F., Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary?. Crit Care Med 22:9 (1994), 1471–1476.
41. 41 Malbrain, M.L., Chiumello, D., Pelosi, P., et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med 33:2 (2005), 315–322.
42. 42 Malbrain, M.L., Cheatham, M.L., Kirkpatrick, A., et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome: definitions. Intensive Care Med 32:11 (2006), 1722–1732.
43. 43 Luckianow, G.M., Ellis, M., Governale, D., Kaplan, L.J., Abdominal compartment syndrome: risk factors, diagnosis, and current therapy. Crit Care Res Pract 2012 (2012), 1–8.
44. 44 De Laet, I., Hoste, E., Verholen, E., De Waele, J.J., The effect of neuromuscular blockers in patients with intra-abdominal hypertension. Intensive Care Med 33:10 (2007), 1811–1814.
45. 45 Cheatham, M.L., Malbrain, M.L., Kirkpatrick, A., et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 33:6 (2007), 951–962.
46. 46 Arrich, J., Holzer, M., Havel, C., Müllner, M., Herkner, H., Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev(2), 2016, CD004128.
47. 47 Riker, R.R., Gagnon, D.J., May, T., Seder, D.B., Fraser, G.L., Analgesia, sedation, and neuromuscular blockade during targeted temperature management after cardiac arrest. Best Pract Res Clin Anaesthesiol 29:4 (2015), 435–450.
48. 48 Heier, T., Caldwell, J.E., Impact of hypothermia on the response to neuromuscular blocking drugs. Anesthesiology 104:5 (2006), 1070–1080.
49. 49 van den Broek, M.P., Groenendaal, F., Egberts, A.C., Rademaker, C.M., Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharmacokinet 49:5 (2010), 277–294.
50. 50 Salciccioli, J.D., Cocchi, M.N., Rittenberger, J.C., et al. Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. Resuscitation 84:12 (2013), 1728–1733.
51. 51 Lascarrou, J.B., Le Gouge, A., Dimet, J., et al. Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: observational study of neurological and infectious outcomes. Resuscitation 85:9 (2014), 1257–1262.
52. 52 Callaway, C.W., Donnino, M.W., Fink, E.L., et al. Part 8: post–cardiac arrest care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 132:18 suppl 2 (2015), S465–S482.
53. 53 Peberdy, M.A., Callaway, C.W., Neumar, R.W., et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122:18 suppl 3 (2010), S768–S786.
54. 54 Loyola, R., Dreher, H.M., Management of pharmacologically induced neuromuscular blockade using peripheral nerve stimulation. Dimens Crit Care Nurs 22:4 (2003), 157–164.
55. 55 Murphy, G.S., Residual neuromuscular blockade: Incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 72:3 (2006), 97–109.
56. 56 Grayling, M., Sweeney, B.P., Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 62:8 (2007), 806–809.
57. 57 Kopman, A.F., Yee, P.S., Neuman, G.G., Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 86:4 (1997), 765–771.
58. 58 Kopman, A.F., In response. Anesth Analg, 112(2), 2011, 483.
59. 59 Murphy, G.S., Szokol, J.W., Marymont, J.H., Greenberg, S.B., Avram, M.J., Vender, J.S., Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 107:1 (2008), 130–137.
60. 60 Lee, C.M., Train-of-4 quantitation of competitive neuromuscular block. Anesth Analg 54:5 (1975), 649–653.
61. 61 Rudis, M.I., Sikora, C.A., Angus, E., et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:4 (1997), 575–583.
62. 62 Kress, J.P., Pohlman, A.S., O'Connor, M.F., Hall, J.B., Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:20 (2000), 1471–1477.
63. 63 Boddi, M., Barbani, F., Abbate, R., et al. Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost 8:1 (2010), 121–128.
64. 64 Baumann, M.H., McAlpin, B.W., Brown, K., et al. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest 126:4 (2004), 1267–1273.
65. 65 Strange, C., Vaughan, L., Franklin, C., Johnson, J., Comparison of train-of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med 156:5 (1997), 1556–1561.
66. 66 Puthucheary, Z., Rawal, J., Ratnayake, G., Harridge, S., Montgomery, H., Hart, N., Neuromuscular blockade and skeletal muscle weakness in critically ill patients: Time to rethink the evidence?. Am J Respir Crit Care Med 185:9 (2012), 911–917.
67. 67 Schakman, O., Gilson, H., Thissen, J.P., Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 197:1 (2008), 1–10.
68. 68 Garnacho-Montero, J., Madrazo-Osuna, J., García-Garmendia, J.L., et al. Critical illness polyneuropathy: risk factors and clinical consequences: a cohort study in septic patients. Intensive Care Med 27:8 (2001), 1288–1296.
69. 69 Fan, E., Dowdy, D.W., Colantuoni, E., et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 42:4 (2014), 849–859.
70. 70 Lenart, S.B., Garrity, J.A., Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation. Am J Crit Care 9:3 (2000), 188–191.
71. 71 Mertes, P.M., Laxenaire, M.C., Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France: seventh epidemiologic survey. Ann Fr Anesthèsie Rèanimation 23:12 (2004), 1133–1143.
72. 72 Ballard, N., Robley, L., Barrett, D., Fraser, D., Mendoza, I., Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15:1 (2006), 86–94.
73. 73 LeBlanc, J.M., Dasta, J.F., Pruchnicki, M.C., Gerlach, A., Cook, C., Bispectral index values, sedation-agitation scores, and plasma lorazepam concentrations in critically ill surgical patients. Am J Crit Care 21:2 (2012), 99–105.